Response to Induction Chemotherapy in Head and Neck Cancer
Author Information
Author(s): Huwyler Francesca, Giger Roland, Bill Ruben, Rauch Daniel
Primary Institution: University of Bern
Hypothesis
How does the response to induction chemotherapy correlate with survival outcomes in patients with locally advanced head and neck squamous cell carcinoma?
Conclusion
Induction chemotherapy is highly effective in treating locally advanced stage head and neck squamous cell carcinoma, and the response to it is a strong prognostic indicator for survival.
Supporting Evidence
- 69.7% of evaluable patients showed a tumor response of 30% or more after induction chemotherapy.
- The 2-year event-free survival rate was 53.1% in the evaluable population.
- Patients with laryngeal or hypopharyngeal tumors that did not respond to induction chemotherapy had a significantly poorer prognosis.
Takeaway
This study shows that if patients with head and neck cancer respond well to a specific type of chemotherapy, they are likely to live longer.
Methodology
A retrospective single-center study analyzing tumor response to induction chemotherapy using survival analysis methods.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the exclusion of patients who did not meet specific criteria.
Limitations
The study is limited by its retrospective design and small sample size, and it only includes patients from a single center.
Participant Demographics
The majority of participants were male, with a median age of 62 years, and included various anatomical sites of tumors.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI 8.7–51.5 for EFS; 95% CI 19.7–NA for OS
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website